Showing results (91-100 of 116) with videos related to

Sort By:
Pageof 12
Neuroscience|May 1, 2007
Characterization of the serotonin transporter knockout rat: a selective change in the functioning of the serotonergic systemJ R Homberg, J D A Olivier, B M G Smits, et al.
Journal of Proteomics|February 13, 2018
Exploration of the platelet proteome in patients with early-stage cancerSiamack Sabrkhany, Marijke J E Kuijpers, Jaco C Knol, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 10, 2012
The good, the bad and the ugly: a tale of miR-101, miR-21 and miR-155 in pancreatic intraductal papillary mucinous neoplasmsS Caponi, N Funel, A E Frampton, et al.
Oral Oncology|June 26, 2020
Expression of let-7i and miR-192 is associated with resistance to cisplatin-based chemoradiotherapy in patients with larynx and hypopharynx cancerDennis Poel, François Rustenburg, Daoud Sie, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 12, 2018
A Phase I Trial of a Guadecitabine (SGI-110) and Irinotecan in Metastatic Colorectal Cancer Patients Previously Exposed to IrinotecanValerie Lee, Judy Wang, Marianna Zahurak, et al.
Cellular Oncology (Dordrecht, Netherlands)|September 12, 2014
Performance of amplicon-based next generation DNA sequencing for diagnostic gene mutation profiling in oncopathologyDaoud Sie, Peter J F Snijders, Gerrit A Meijer, et al.
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|July 27, 2023
Outcomes in Dutch DPP6 risk haplotype for familial idiopathic ventricular fibrillation: a focused updateAuke T Bergeman, Wiert F Hoeksema, Martijn H van der Ree, et al.
Cancer Cell|January 24, 2012
Rapid decrease in delivery of chemotherapy to tumors after anti-VEGF therapy: implications for scheduling of anti-angiogenic drugsAstrid A M Van der Veldt, Mark Lubberink, Idris Bahce, et al.
Breast Cancer Research and Treatment|April 16, 2026
External validation of PREDICT Breast v3.1 for overall survival in international cohorts, including young and invasive lobular subgroupsElfi M Verheul, Frank Doornkamp, Iurii Petrov, et al.
Advances in Therapy|October 17, 2018
Pharmacokinetic Effects and Safety of Olaparib Administered with Endocrine Therapy: A Phase I Study in Patients with Advanced Solid TumoursRuth Plummer, Henk M Verheul, Filip Y F L De Vos, et al.
Pageof 12